IL111467A0 - Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors - Google Patents

Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors

Info

Publication number
IL111467A0
IL111467A0 IL11146794A IL11146794A IL111467A0 IL 111467 A0 IL111467 A0 IL 111467A0 IL 11146794 A IL11146794 A IL 11146794A IL 11146794 A IL11146794 A IL 11146794A IL 111467 A0 IL111467 A0 IL 111467A0
Authority
IL
Israel
Prior art keywords
alpha
cholestan
aza
inhibitors
beta
Prior art date
Application number
IL11146794A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL111467A0 publication Critical patent/IL111467A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
IL11146794A 1993-11-12 1994-10-31 Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors IL111467A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15300693A 1993-11-12 1993-11-12

Publications (1)

Publication Number Publication Date
IL111467A0 true IL111467A0 (en) 1994-12-29

Family

ID=22545401

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11146794A IL111467A0 (en) 1993-11-12 1994-10-31 Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors

Country Status (4)

Country Link
AU (1) AU8133294A (en)
IL (1) IL111467A0 (en)
WO (1) WO1995013077A1 (en)
ZA (1) ZA948909B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE195741T1 (en) 1994-05-19 2000-09-15 Merck & Co Inc OXIDATION OF STEROIDS WITH ALLYLIC GROUPS
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
AU694576B2 (en) * 1994-10-21 1998-07-23 Merck & Co., Inc. Combination method for acne treatment
JP2001523259A (en) * 1997-05-07 2001-11-20 ノヴォファーム リミテッド 4-aza-steroids
US20080125403A1 (en) * 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9006023D0 (en) * 1990-03-16 1990-05-09 Smithkline Beecham Corp Synergistic compositions
WO1992007586A1 (en) * 1990-10-31 1992-05-14 Beecham Group Plc Topical composition with retinoid penetration enhancer
IL101245A0 (en) * 1991-03-20 1992-11-15 Merck & Co Inc Pharmaceutical compositions for the treatment of prostatic cancer
US5237064A (en) * 1992-05-20 1993-08-17 Merck & Co., Inc. Process for producing 7β-substituted-aza-5αandrostan-3-ones
SK137994A3 (en) * 1992-05-20 1995-04-12 Merck & Co Inc 7-beta-substituted-4-aza-5-alpha-cholestan-ons their using for production of pharmaceutical agent and pharmaceutical agent containing them

Also Published As

Publication number Publication date
AU8133294A (en) 1995-05-29
WO1995013077A1 (en) 1995-05-18
ZA948909B (en) 1995-10-10

Similar Documents

Publication Publication Date Title
IL111785A0 (en) Dp-iv inhibitors and pharmaceutical compositions containing them
GB9319568D0 (en) Pharmaceutical compositions and usages
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
HUP9702035A3 (en) Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them
HUP9702036A3 (en) Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them
HUP9702034A3 (en) Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them
IL109503A0 (en) Hiv protease inhibitors and pharmaceutical compositions containing them
HUP9900964A3 (en) Protease inhibitors and pharmaceutical compositions containing these compounds
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
NZ314376A (en) Substituted sulphonamides and pharmaceutical compositions
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
PL313769A1 (en) Azole derivative and pharmaceutical composition thereof
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
NZ233122A (en) Synergistic pharmaceutical composition comprising ketanserine and an ace inhibitor
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
IL110724A (en) Retroviral protease inhibitors and pharmaceutical compositions containing them
ZA963397B (en) Esters and pharmaceutical compositions
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
IL109726A0 (en) Oligomer conjugate and pharmaceutical compositions containing it
IL111467A0 (en) Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors
IL111692A0 (en) Quinoxalines and pharmaceutical compositions containing them
HU9402538D0 (en) Pharmaceutical composition and optical isomerization inhibitor
PH30103A (en) Pharmaceutical compositions containing amidines and novel amidines